AstraZeneca Pharma India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
AstraZeneca Pharma India has informed the stock exchanges that its trading window for dealing in equity shares will be closed starting June 16, 2025. The closure is in line with SEBI's Insider Trading Regulations and the company's own code of conduct. The window will reopen 48 hours after the company declares its unaudited financial results for the quarter ending June 30, 2025 (Q1 FY26). This is a standard compliance measure taken before the announcement of quarterly results to prevent insider trading by insiders and designated persons.
This is a routine regulatory filing and does not impact shareholders directly. However, it signals that the company's Q1 FY26 earnings results are expected soon, which investors should watch for as a potential stock-moving event.